A protective effect of apolipoprotein E e2 allele on dementia in Down's syndrome

Biological Psychiatry

Volumn 43, Issue 6, 1998, Pages 397-400

  Tyrrell, Janette ^a   Cosgrave, Mary ^a   Hawi, Ziarih ^a   McPherson, Janet ^b   O'Brien, Catherine ^a   McCalvert, John ^b   McLaughlin, Martin ^a   Lawlor, Brian ^a   Gill, Michael ^a,c  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b Muckamore Abbey Hospital   (Ireland)

^c ST JAMES S HOSPITAL   (Ireland)

Author keywords

Alzheimer's disease; Apolipoprotein E; Dementia; Down's syndrome; Genetics

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DNA DETERMINATION; DOWN SYNDROME; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ALLELES; APOLIPOPROTEIN E2; APOLIPOPROTEINS E; DEMENTIA; DNA; DOWN SYNDROME; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 0032521531     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00481-2     Document Type: Article

References (22)

1. Aylward E, Burt D, Thorpe L, Lai F, Dalton A. Diagnosis of dementia in individuals with intellectual disability. Washington: American Association on Mental Retardation 1995.
2. Cosgrave M, Tyrrell J, Dreja H, Hawi Z, Lawlor B, Gill M (1996): Lower frequency of ApoE e4 allele in an older Down's syndrome population. Biol Psychiatry 40:811-813.
3. Devenny D, Silverman W, Hill A, Jenkins E, Sersen E, Wisniewski K (1996): Normal ageing in adults with Down's syndrome: A longitudinal study. J Intellect Disabil Res 40:208-221.
4. Eto M, Watanabe K, Makino I (1989): Increased frequencies of apolipoprotein e2 and e4 in patients with ischemic heart disease. Clin Genet 36:183-188.
5. Evenhuis HM (1990): The natural history of dementia in Down's syndrome. Arch Neurol 47:263-267.
6. Hardy J, Crook R, Perry R, Raghavan R, Roberts G (1994): ApoE genotype and Down's syndrome. Lancet 343:979-980.
7. Karlinsky H (1986): Alzheimer's disease in Down's syndrome. J Am Geriatr Soc 34:728-734.
8. Lai F, Williams RS (1993): A prospective study of Alzheimer's disease in Down's syndrome. Arch Neurol 46:849-853.
9. Ma J, Yee A, Brewer H, et al (1994): Amyloid associated proteins alpha-1-antichymotrypsin and apolipoprotein E promote assembly of amyloid B protein into filaments. Nature 372:92-94.
10. Mann DMA (1988): Alzheimer's disease and Down's syndrome. Histopathology 13:125-137.
11. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993): Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699.
12. Prasher VP, Krishnan VHR (1993): Age of onset and duration of dementia in people with Down's syndrome. Int J Geriatr Psychiatry 8:915-922.
13. Royston M, Mann D, Pickering-Brown S, et al (1994): Apolipoprotein E e2 allele promotes longevity and protects patients with Down's syndrome from dementia. Neuroreport 5:2583-2585.
14. Saunders A, Strittmatter W, Schmechel D, et al (1993): Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472.
15. Schacter F, Faure-Delanef L, Guenot F, et al (1994): Genetic associations with human longevity at the ApoE and ACE loci. Nat Genet 6:29-32.
16. Schupf N, Kapell D, Lee JH, et al (1996): Onset of dementia is associated with apolipoprotein E e4 in Down's syndrome. Ann Neurol 40:799-801.
17. Strittmatter W, Saunders A, Schmechel D, et al (1993): Apolipoprotein E high affinity binding to beta-amyloid and increased frequency of type 4 allele in familiar Alzheimer's. Proc Natl Acad Sci USA 90:1977-1981.
18. Talbot C, Lendon C, Craddock N, Shears S, Morris J, Goate A (1994): Protection against Alzheimer's disease with ApoE e2. Lancet 343:1432-1433.
19. Tyrrell J, Cosgrave M, McLaughlin M, Lawlor B (1996): Dementia in an Irish population of Down's syndrome people. Ir J Psychol Med 13:51-55.
20. Van Gool W, Evenhuis H, van Duijn C (1995): A case-control study of apoliprotein E genotypes in Alzheimers disease associated with Down's syndrome. Ann Neurol 38:225-230.
21. Wisniewski K, Dalton A, Crapper McLachlan DR, Wen GY, Wisniewski HM (1985): Alzheimer's disease in Down's syndrome: Clinicopathological studies. Neurology 35:957-961.
22. Wisniewski T, Morelli L, Weigel J, Levy E, Wisniewski H, Frangione B (1995): The influence of apolipoprotein E isotopes on Alzheimer's disease pathology in 40 cases of Down's syndrome. Ann Neurol 37:136-138.